Plasma VEGF - a candidate biomarker for response to treatment with bevacizumab in HHT patients. Liu DT, Frohne A, Koenighofer M, Frei K, et al. Rhinology 2020;58:18-24.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu DT, Frohne A, Koenighofer M, Frei K, et al. Plasma VEGF - a candidate biomarker for response to treatment with bevacizumab in HHT patients. Rhinology 2020;58:18-24.
PMID: 31681913